We are submitting the Company''s reply to queries raised by BSE Limited for the Corporate Announcement of the Company submitted on 2nd May 2025 pertaining to resignation of Mr. Sachin Mehta as Chief Financial Officer and appointment of Mr. Manoj Lodha as Chief Financial Officer of the Company, effective 1st May, 2025. Request you to take the same on record.
Announcement under Regulation 30 (LODR)-Change in Directorate
Filed with BSE · · 6 pages · English
Release
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Apr 26 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Apr 24 2025
- Financial Results For The Financial Year Ended March 31, 2025
- Sudarshan Pharma Industries Ltd Press Release Apr 21 2025
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Sudarshan Pharma Industries Ltd Press Release May 29 2025
- Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
- Sudarshan Pharma Industries Ltd Press Release Jun 04 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries